IRIS Accounts Production v23.2.0.158 03831735 director 1.11.22 31.10.23 31.10.23 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh038317352022-10-31038317352023-10-31038317352022-11-012023-10-31038317352021-10-31038317352021-11-012022-10-31038317352022-10-3103831735ns10:Originalns15:EnglandWales2022-11-012023-10-3103831735ns14:PoundSterlingns10:Original2022-11-012023-10-3103831735ns10:Originalns10:Director12022-11-012023-10-3103831735ns10:Original2022-11-012023-10-3103831735ns10:Original2023-10-3103831735ns10:Originalns10:PrivateLimitedCompanyLtd2022-11-012023-10-3103831735ns10:Originalns10:SmallEntities2022-11-012023-10-3103831735ns10:Originalns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3103831735ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-11-012023-10-3103831735ns10:SmallCompaniesRegimeForAccountsns10:Original2022-11-012023-10-3103831735ns10:Originalns10:FullAccounts2022-11-012023-10-3103831735ns10:Originalns10:OrdinaryShareClass12022-11-012023-10-3103831735ns10:Originalns10:OrdinaryShareClass22022-11-012023-10-3103831735ns10:CompanySecretary1ns10:Original2022-11-012023-10-3103831735ns10:Originalns10:RegisteredOffice2022-11-012023-10-3103831735ns10:Original2022-10-3103831735ns10:Originalns5:CurrentFinancialInstruments2023-10-3103831735ns10:Originalns5:CurrentFinancialInstruments2022-10-3103831735ns10:Originalns5:Non-currentFinancialInstruments2023-10-3103831735ns10:Originalns5:Non-currentFinancialInstruments2022-10-3103831735ns5:ShareCapitalns10:Original2023-10-3103831735ns5:ShareCapitalns10:Original2022-10-3103831735ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-10-3103831735ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-10-3103831735ns10:Originalns5:PlantMachinery2022-11-012023-10-3103831735ns10:Original2021-11-012022-10-3103831735ns10:Originalns5:PlantMachinery2022-10-3103831735ns10:Originalns5:PlantMachinery2023-10-3103831735ns10:Originalns5:PlantMachinery2022-10-3103831735ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3103831735ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-3103831735ns10:Originalns5:HirePurchaseContractsns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3103831735ns10:Originalns5:HirePurchaseContractsns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-3103831735ns5:BetweenOneFiveYearsns10:Originalns5:HirePurchaseContracts2023-10-3103831735ns5:BetweenOneFiveYearsns10:Originalns5:HirePurchaseContracts2022-10-3103831735ns10:Originalns5:HirePurchaseContracts2023-10-3103831735ns10:Originalns5:HirePurchaseContracts2022-10-3103831735ns10:Originalns5:WithinOneYear2023-10-3103831735ns10:Originalns5:WithinOneYear2022-10-3103831735ns5:BetweenOneFiveYearsns10:Original2023-10-3103831735ns5:BetweenOneFiveYearsns10:Original2022-10-3103831735ns10:Originalns5:MoreThanFiveYears2023-10-3103831735ns10:Originalns5:MoreThanFiveYears2022-10-3103831735ns10:Originalns5:AllPeriods2023-10-3103831735ns10:Originalns5:AllPeriods2022-10-3103831735ns5:Securedns10:Original2023-10-3103831735ns5:Securedns10:Original2022-10-3103831735ns10:Originalns10:OrdinaryShareClass12023-10-3103831735ns10:Originalns10:OrdinaryShareClass22023-10-31
REGISTERED NUMBER: 03831735 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2023

for

Surrey Diagnostics Limited

Surrey Diagnostics Limited (Registered number: 03831735)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Surrey Diagnostics Limited

Company Information
for the Year Ended 31 October 2023







Director: J N Bleby





Secretary: J N Bleby





Registered office: 76 Dunsfold Park
Dunsfold
Cranleigh
Surrey
GU6 8TB





Registered number: 03831735 (England and Wales)





Accountants: Pinkham Blair
Chartered Accountants
87a High Street
The Old Town
Hemel Hempstead
Hertfordshire
HP1 3AH

Surrey Diagnostics Limited (Registered number: 03831735)

Balance Sheet
31 October 2023

2023 2022
Notes £ £ £ £
Fixed assets
Tangible assets 4 40,527 50,108

Current assets
Stocks 105,665 95,635
Debtors 5 159,368 136,679
Cash at bank and in hand 106 497
265,139 232,811
Creditors
Amounts falling due within one year 6 199,521 195,981
Net current assets 65,618 36,830
Total assets less current liabilities 106,145 86,938

Creditors
Amounts falling due after more than
one year

7

(32,797

)

(68,280

)

Provisions for liabilities (7,515 ) (7,538 )
Net assets 65,833 11,120

Capital and reserves
Called up share capital 10 1,002 1,002
Retained earnings 64,831 10,118
Shareholders' funds 65,833 11,120

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Surrey Diagnostics Limited (Registered number: 03831735)

Balance Sheet - continued
31 October 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 6 February 2024 and were signed by:





J N Bleby - Director


Surrey Diagnostics Limited (Registered number: 03831735)

Notes to the Financial Statements
for the Year Ended 31 October 2023

1. Statutory information

Surrey Diagnostics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue recognition
Fee income represents revenue earned under contracts to provide services. Revenue is recognised as earned, to the extent that the firm obtains the right to consideration in exchange for its performance under these contracts. It is measured at the fair value of the right to consideration, which represents amounts chargeable to clients, including expenses and disbursements, but net of VAT.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Surrey Diagnostics Limited (Registered number: 03831735)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

2. Accounting policies - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. Employees and directors

The average number of employees during the year was 8 (2022 - 8 ) .

Surrey Diagnostics Limited (Registered number: 03831735)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

4. Tangible fixed assets
Plant and
machinery
etc
£
Cost
At 1 November 2022 299,753
Additions 481
At 31 October 2023 300,234
Depreciation
At 1 November 2022 249,645
Charge for year 10,062
At 31 October 2023 259,707
Net book value
At 31 October 2023 40,527
At 31 October 2022 50,108

5. Debtors: amounts falling due within one year
2023 2022
£ £
Trade debtors 125,574 116,843
Other debtors 33,794 19,836
159,368 136,679

6. Creditors: amounts falling due within one year
2023 2022
£ £
Bank loans and overdrafts 70,305 72,623
Hire purchase contracts (see note 8)
7,993

7,508
Trade creditors 82,670 56,192
Taxation and social security 29,757 45,549
Other creditors 8,796 14,109
199,521 195,981

Surrey Diagnostics Limited (Registered number: 03831735)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

7. Creditors: amounts falling due after more than one year
2023 2022
£ £
Bank loans 31,333 58,823
Hire purchase contracts (see note 8)
1,464

9,457
32,797 68,280

8. Leasing agreements

Minimum lease payments fall due as follows:

Hire purchase contracts
2023 2022
£ £
Net obligations repayable:
Within one year 7,993 7,508
Between one and five years 1,464 9,457
9,457 16,965

Non-cancellable
operating leases
2023 2022
£ £
Within one year 64,582 64,582
Between one and five years 236,801 258,328
In more than five years - 43,055
301,383 365,965

9. Secured debts

The following secured debts are included within creditors:

2023 2022
£ £
Bank overdrafts 40,207 42,773
Bank loans 61,431 88,673
101,638 131,446

Surrey Diagnostics Limited (Registered number: 03831735)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

10. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £ £
1,000 Ordinary A £1 1,000 1,000
2 Ordinary B £1 2 2
1,002 1,002